Merck KGaA : Site visit feedback – Decreasing headwind
>Underlying market intact - We organised a site visit of Merck’s Life Sciences business including the new mRNA showroom and hosted a group meeting with the divisional CEO Matthias Heinzel who described an underlying healthy demand from the biopharmaceutical industry. The development in China is seen as more muted with growth in the mid to high-single-digit territory on the back of a challenging macro environment despite overall healthy fundamentals (investments in hea...Merck is a global science and technology company based in Germany. Co. diversifies its activities into four business divisions: Merck Serono, Consumer Health, Performance Materials and Merck Millipore. The Merck Serono develops, manufactures and markets prescription drugs to treat cancer, multiple sclerosis, infertility, growth disorders, and selected cardiovascular and metabolic diseases. The Consumer Health manufactures and markets over-the-counter drugs addressing health themes such as mobility, women's and children's health, cough and cold. Performance Materials is a specialty chemicals business. The Merck Millipore is the supplier of products and services for the life science industry.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.